Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025)
Historic Accounts Payables for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $5.9 million.
- Zhengye Biotechnology Holding's Accounts Payables changed N/A to $5.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.9 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2024, which is 746.18% down from last year.
- Zhengye Biotechnology Holding's Accounts Payables amounted to $5.9 million in Q2 2025.
- In the past 5 years, Zhengye Biotechnology Holding's Accounts Payables ranged from a high of $6.3 million in Q4 2023 and a low of $5.9 million during Q2 2025
- Moreover, its 3-year median value for Accounts Payables was $6.0 million (2024), whereas its average is $6.1 million.
- Data for Zhengye Biotechnology Holding's Accounts Payables shows a peak YoY increase of 568.88% (in 2024) and a maximum YoY decrease of 568.88% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Zhengye Biotechnology Holding's Accounts Payables stood at $6.3 million in 2023, then dropped by 5.69% to $6.0 million in 2024, then decreased by 1.06% to $5.9 million in 2025.
- Its Accounts Payables stands at $5.9 million for Q2 2025, versus $6.0 million for Q4 2024 and $6.3 million for Q4 2023.